Early research (Phase 1)Ended earlyNCT02437916What this trial is testingSafety Study of AMG 228 to Treat Solid TumorsWho this might be right forAdvanced MalignancyAdvanced Solid TumorsCancer+8 more Amgen 30
Testing effectiveness (Phase 2)Study completedNCT03892642What this trial is testingAvelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder CancerWho this might be right forBladder Cancer University of Oklahoma 18
Not applicableStudy completedNCT04647981What this trial is testingDiagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.Who this might be right forNon-Invasive Bladder Urothelial CarcinomaNon-Invasive Bladder Papillary Urothelial Carcinoma, Low GradeNon-Invasive Bladder Papillary Urothelial Carcinoma, High Grade Clinique Beau Soleil 320
Large-scale testing (Phase 3)Study completedNCT00729287What this trial is testingSelenium in Preventing Cancer Recurrence in Patients With Bladder CancerWho this might be right forBladder Cancer KU Leuven 276
Large-scale testing (Phase 3)Ended earlyNCT01200992What this trial is testingEfficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder CancerWho this might be right forBladder NeoplasmNeoplasm Recurrence, LocalTransitional Cell, Carcinoma+2 more Bioniche Life Sciences Inc. 84
Large-scale testing (Phase 3)UnknownNCT03992911What this trial is testingSafety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine CarcinomaWho this might be right forNeuroendocrine Carcinoma of the Bladder Peking University 336
Not applicableUnknownNCT01826565What this trial is testingComparison of Two Insertion Technique of I-gelWho this might be right forProstate CancerProstate TumorBladder Cancer+1 more Seoul National University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02788201What this trial is testingGenomic Based Assignment of Therapy in Advanced Urothelial CarcinomaWho this might be right forUrothelial CarcinomaBladder CancerUrinary Bladder Neoplasms National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Ended earlyNCT00087295What this trial is testingS0400, FR901228 in Treating Patients With Advanced Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 6
Not applicableLooking for participantsNCT07494864What this trial is testingEffects of Microbiological and Immunological Factors on the Lower Urinary TractWho this might be right forAsymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder EmptyingAsymptomatic Bacteriuria in Subjects Relying on Some Type of CatheterRecurrent Non-catheter Associated UTIs+5 more University of Zurich 800
Large-scale testing (Phase 3)Ended earlyNCT00352079What this trial is testingBCG With or Without Gefitinib in Treating Patients With High-Risk Bladder CancerWho this might be right forBladder Cancer NCIC Clinical Trials Group 41
Not applicableStudy completedNCT03862105What this trial is testingTesting the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder CancerWho this might be right forInvasive Bladder Cancer UNC Lineberger Comprehensive Cancer Center 33
Post-approval studies (Phase 4)Looking for participantsNCT05962541What this trial is testingVesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)Who this might be right forNon-muscle-invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial CarcinomaHigh Risk Non-Muscle Invasive Bladder Urothelial Carcinoma University of Roma La Sapienza 327
Not applicableUnknownNCT03864302What this trial is testingSimulation in Transurethral Bladder Cancer SurgeryWho this might be right forVirtual RealityEducationBladder Cancer Rigshospitalet, Denmark 34
Large-scale testing (Phase 3)Looking for participantsNCT06960577What this trial is testingPerioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)Who this might be right forUrinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more AstraZeneca 150
Early research (Phase 1)Study completedNCT03359239What this trial is testingAtezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial CancerWho this might be right forUrothelial/Bladder Cancer, Nos Matthew Galsky 10
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07800507What this trial is testingTrop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder CancerWho this might be right forNMIBC Yunnan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03636256What this trial is testingEvaluation of NanoDoce® in Participants With Urothelial CarcinomaWho this might be right forBladder CancerUrothelial CarcinomaUrinary Bladder Neoplasm+6 more NanOlogy, LLC 36
Early research (Phase 1)Study completedNCT05858736What this trial is testingSafety, PK and Efficacy of AI-061 in Advanced Solid TumorsWho this might be right forMelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more OncoC4, Inc. 18